Stock Comparison

ROIV vs VRTX

Roivant Sciences Ltd and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ROIV

Roivant Sciences Ltd

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$26.62B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

—

25.7

Price/Sales

3,533.7

9.9

Price/Book

6.3

6.1

EV/EBITDA

0.8

23.2

Dividend Yield

—

Profitability

Net Margin

-3629.19%

35.40%

Operating Margin

-15560.57%

38.97%

Return on Equity

-8.52%

23.50%

Return on Assets

-16.50%

11.90%

Growth (YoY)

Revenue Growth

-33.50%

12.50%

Earnings Growth

-96.10%

8.00%

Price & Risk

Beta

1.1

0.3

52-Week High

$36.81

$529.65

52-Week Low

$11.64

$376.62

Analyst Target

$38.91

$559.28

Compare ROIV and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.